U.S. flag

An official website of the United States government

NM_000530.8(MPZ):c.371C>T (p.Thr124Met) AND not provided

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Jul 1, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000517355.35

Allele description [Variation Report for NM_000530.8(MPZ):c.371C>T (p.Thr124Met)]

NM_000530.8(MPZ):c.371C>T (p.Thr124Met)

Gene:
MPZ:myelin protein zero [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_000530.8(MPZ):c.371C>T (p.Thr124Met)
HGVS:
  • NC_000001.11:g.161306785G>A
  • NG_008055.1:g.8188C>T
  • NM_000530.8:c.371C>TMANE SELECT
  • NM_001315491.2:c.371C>T
  • NP_000521.2:p.Thr124Met
  • NP_000521.2:p.Thr124Met
  • NP_001302420.1:p.Thr124Met
  • LRG_256t1:c.371C>T
  • LRG_256:g.8188C>T
  • LRG_256p1:p.Thr124Met
  • NC_000001.10:g.161276575G>A
  • NM_000530.5:c.401C>T
  • NM_000530.6:c.371C>T
  • NM_000530.7:c.371C>T
  • NP_000521.1:p.Thr134Met
  • P25189:p.Thr124Met
Protein change:
T124M; THR124MET
Links:
UniProtKB: P25189#VAR_004529; OMIM: 159440.0016; dbSNP: rs121913595
NCBI 1000 Genomes Browser:
rs121913595
Molecular consequence:
  • NM_000530.8:c.371C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001315491.2:c.371C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000614106Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics criteria)
Pathogenic
(Oct 9, 2020)
unknownclinical testing

PubMed (13)
[See all records that cite these PMIDs]

SCV001249783CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(Jul 1, 2022)
germlineclinical testing

Citation Link,

SCV002520050Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 19, 2021)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

SCV002540333GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Jun 29, 2022)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Axonal and demyelinating forms of the MPZ Thr124Met mutation.

Kurihara S, Adachi Y, Wada K, Adachi A, Ohama E, Nakashima K.

Acta Neurol Scand. 2003 Sep;108(3):157-60.

PubMed [citation]
PMID:
12911457

Charcot-Marie-Tooth families in Japan with MPZ Thr124Met mutation.

Kurihara S, Adachi Y, Imai C, Araki H, Hattori N, Numakura C, Lin Y, Hayasaka K, Sobue G, Nakashima K.

J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1492-4.

PubMed [citation]
PMID:
15377707
PMCID:
PMC1738775
See all PubMed Citations (20)

Details of each submission

From Athena Diagnostics, SCV000614106.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (13)

Description

This variant was not reported in large, multi-ethnic, general populations (http://gnomad.broadinstitute.org). This variant segregates with disease in multiple families. This variant occurs as the most likely explanation for disease in a significant number of internal cases, suggesting this variant is associated with disease. Computational tools predict that this variant is damaging. The variant is located in a region that is considered important for protein function and/or structure.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV001249783.26

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided

Description

MPZ: PM1, PM2, PP1:Moderate, PS3:Moderate, PS4:Moderate

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV002520050.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

PP1, PM1, PM2, PS3_moderate, PS4

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV002540333.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Identified in multiple unrelated patients with Charcot-Marie-Tooth (Yoshihara et al., 2000; Gallardo et al., 2009; Liu et al., 2013; Bergamin et al., 2014); Published functional studies demonstrate a damaging effect (Grandis et al., 2008; Lee et al., 2010); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are often considered pathogenic (HGMD); This variant is associated with the following publications: (PMID: 15159512, 19928689, 24819634, 18563718, 18337304, 20461396, 19629567, 10835936, 9452091, 25720167, 26234237, 16279991, 24028194, 15377707, 10071056, 34210210, 33825325, 22820753, 20301384, 16775239, 12911457, 31827005, 30018047, 29516875, 10329755, 25802885, 29687021, 31211173, 12948789, 12207153, 10764043, 26310628, 10923043)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024